Tech Company Financing Transactions
Cylene Pharmaceuticals Funding Round
Cylene Pharmaceuticals, based in San Diego, secured $26.3 million from BioVentures Investors, Coastview Capital and Mitsui & Co. Venture Partners.
Transaction Overview
Company Name
Announced On
5/25/2005
Transaction Type
Venture Equity
Amount
$26,300,000
Round
Series B
Investors
BioVentures Investors (Mickey Kim)
Coastview Capital (Stella Sung)
Proceeds Purpose
The funding will allow Cylene to advance CX-3543, its lead product for the treatment of multiple cancers, into clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5820 Nancy Ridge Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cylene Pharmaceuticalsdiscovers, develops and commercializessmall molecule drugs that target nucleolus and kill cancer cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Rice
Co-Founder
Daniel Hoff
VP - Bus. Development
Sean O'Brien
VP - Regulatory Affairs
John Lim
Browse more venture capital transactions:
Prev: 5/25/2005: Quorum Systems venture capital transaction
Next: 5/25/2005: Aspen Aerogels venture capital transaction
Share this article
Where The Data Comes From
We record funding rounds that are announced publicly. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs